The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIP.L Regulatory News (CIP)

  • There is currently no data for CIP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Payment of Additional Director Fees

25 Apr 2022 08:45

RNS Number : 1826J
CIP Merchant Capital Ltd
25 April 2022
 

 

25 April 2022

 

CIP MERCHANT CAPITAL LIMITED

("CIP" or the "Company")

 

Payment of Additional Director Fees

 

The Board of CIP announces that it has agreed to make a one-off additional payment of, in aggregate, £57,500, to the Company's directors in connection with the additional work undertaken by the Board, beyond the scope of their existing contractual arrangements with the Company, in relation to addressing Corporation Financière Européenne S.A.'s ("CFE") protracted stake building, announcement of a possible offer for CIP, and subsequent hostile offer for CIP, over the past 18 months (the "Additional Director Fees").

 

The Additional Director Fees are to be paid as follows:

 

Director

Additional Director Fees

Adrian Collins

£17,500

John Falla

£15,000

Robert King

£12,500

Piero Sansalone

£12,500

 

 

Related Party Transaction

 

The payment of the Additional Director Fees is deemed to be a related party transaction under the AIM Rules. Due to the participation of all of the Company's directors, there is no director independent of the Additional Director Fees arrangement to provide the necessary AIM Rule 13 related party transaction opinion.

 

Accordingly, Strand Hanson Limited, the Company's Nominated Adviser, is satisfied that the Additional Director Fees are fair and reasonable, insofar as the Shareholders are concerned.

 

 

Enquiries:

 

CIP Merchant Capital Limited

Wikus van Schalkwyk

 

+44 1481 749363

Strand Hanson Limited (Financial & Nominated Adviser and Broker)

Stuart Faulkner / Matthew Chandler / James Bellman / Rob Patrick

+44 20 7409 3494

 

 

The information contained in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (which applies in the United Kingdom by operation of the European Union (Withdrawal) Act 2018 (as amended)). The person responsible for arranging release of this announcement on behalf of CIP is Adrian Collins.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDELBLLZLXBBV
Date   Source Headline
6th Nov 20187:00 amRNSNet Asset Value(s)
30th Oct 20187:00 amRNSNet Asset Value(s)
23rd Oct 20187:00 amRNSNet Asset Value(s)
16th Oct 20187:00 amRNSNet Asset Value(s)
11th Oct 20187:00 amRNSHeads of Terms for the fourth investment
9th Oct 20187:00 amRNSNet Asset Value(s)
2nd Oct 20187:00 amRNSNet Asset Value(s)
28th Sep 20187:00 amRNSUnaudited Interim Financial Statements
25th Sep 20187:00 amRNSNet Asset Value(s)
18th Sep 20187:00 amRNSNet Asset Value(s)
11th Sep 20187:00 amRNSNet Asset Value(s)
4th Sep 20187:00 amRNSNet Asset Value(s)
31st Aug 201812:33 pmRNSFurther Investment in Alkemy
29th Aug 20187:00 amRNSNet Asset Value(s)
21st Aug 20187:00 amRNSNet Asset Value(s)
14th Aug 20187:00 amRNSNet Asset Value(s)
9th Aug 20182:36 pmRNSFurther Investment in Orthofix
7th Aug 20187:00 amRNSNet Asset Value(s)
31st Jul 20187:00 amRNSNet Asset Value(s)
26th Jul 20187:00 amRNSThird Investment
24th Jul 20187:00 amRNSNet Asset Value(s)
17th Jul 20187:00 amRNSNet Asset Value
16th Jul 20187:00 amRNSSecond Investment
10th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20187:00 amRNSNet Asset Value(s)
26th Jun 20187:00 amRNSNet Asset Value(s)
19th Jun 20187:00 amRNSNet Asset Value(s)
13th Jun 20186:00 pmRNSHolding(s) in Company
13th Jun 20186:00 pmRNSHolding(s) in Company
13th Jun 20186:00 pmRNSHolding(s) in Company
12th Jun 20188:58 amRNSNet Asset Value(s)
5th Jun 20187:00 amRNSNet Asset Value(s)
30th May 20187:00 amRNSNet Asset Value(s)
22nd May 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
9th May 20187:00 amRNSNet Asset Value(s)
1st May 20187:00 amRNSNet Asset Value(s)
24th Apr 20187:00 amRNSNet Asset Value(s)
19th Apr 20184:13 pmRNSHolding(s) in Company
17th Apr 20187:00 amRNSNet Asset Value(s)
10th Apr 20187:00 amRNSNet Asset Value(s)
9th Apr 20189:18 amRNSCompletion of Investment in Saffron Energy plc
4th Apr 20187:00 amRNSNet Asset Value(s)
27th Mar 20187:00 amRNSNet Asset Value(s)
20th Mar 20187:00 amRNSNet Asset Value(s)
13th Mar 20187:00 amRNSNet Asset Value(s)
6th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20183:20 pmRNSFurther update on Investment in Saffron Energy plc
28th Feb 201810:00 amRNSAcquisition
27th Feb 20187:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.